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Tetraspanins (Tspans) are a family of four-span transmembrane proteins, known as 
plasma membrane “master organizers.” They form Tspan-enriched microdomains 
(TEMs or TERMs) through lateral association with one another and other membrane 
proteins. If multiple microdomains associate with each other, larger platforms can form. 
For infection, viruses interact with multiple cell surface components, including receptors, 
activating proteases, and signaling molecules. It appears that Tspans, such as CD151, 
CD82, CD81, CD63, CD9, Tspan9, and Tspan7, coordinate these associations by con-
centrating the interacting partners into Tspan platforms. In addition to mediating viral 
attachment and entry, these platforms may also be involved in intracellular trafficking of 
internalized viruses and assist in defining virus assembly and exit sites. In conclusion, 
Tspans play a role in viral infection at different stages of the virus replication cycle. The 
present review highlights recently published data on this topic, with a focus on events 
at the plasma membrane. In light of these findings, we propose a model for how Tspan 
interactions may organize cofactors for viral infection into distinct molecular platforms.
Keywords: tetraspanin, microdomain, virus, entry, endocytosis, trafficking, budding, receptor
inTRODUCTiOn
The contents of the cell are protected from the extracellular surroundings by the plasma membrane: 
a lipid bilayer densely populated with protein (1, 2). These proteins are specifically distributed 
throughout the membrane, a phenomenon associated with lipid microdomains, rafts, phases, or 
clusters. Local enrichments can be explained by spontaneous self-organization driven by thermo-
dynamic principles (3). Conversely, the composition and architecture of membrane proteins is also 
actively remodeled in order to control specific functions.
Viruses are genetic entities that can form particles of sizes up to 200 nm and require multiple 
steps to overcome the cell barrier during entry and egress. To gain access into the cell, viruses employ 
different host receptors, proteases, and signaling molecules. After internalization via endocytosis, 
non-enveloped viruses escape the membranous organelle system in order to deliver viral genetic 
information into the cytoplasm or nucleus (4–6). Entry of enveloped viruses occurs through fusion 
of the viral and cellular membrane at the plasma membrane or in intracellular compartments (7). 
Abbreviations: CD, cluster of differentiation; CDV, canine distemper virus; CLDN1, claudin; CoV, coronavirus; EBV, Epstein–
Barr virus; ESCRT, endosomal sorting complexes required for transport; FIV, feline immunodeficiency virus, GFRs, growth 
factor receptors; HAV, hepatitis A virus; HCMV, human cytomegalovirus; HCV, hepatitis C virus; HIV, human immunodefi-
ciency virus; HPV, human papillomavirus; HSV, herpes simplex virus; IAV, influenza A virus; ITGB1, integrin β1; LEL, large 
extracellular loop; LUJV, Lujo virus; MAPK, mitogen-activated protein kinase; MVB, multivesicular body; Ras, rat sarcoma; 
SR-BI, scavenger receptor type B class I; TEMs or TERMs, tetraspanin-enriched microdomains; TIRF, total internal reflection 
fluorescence microscopy; TM, trans-membrane; Tspan, tetraspanin; vDNA, viral DNA.
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Each viral entry mechanism involves its own set of unique inter-
actions between the virus and the cellular membrane system. 
Members of the tetraspanin (Tspan) protein family are localized 
to membranes and as such, associate directly and indirectly, with 
multiple steps of viral infection.
TeTRASPAninS
Tetraspanins are a family of small transmembrane proteins (8) 
that function in cell migration, signal-transduction, intracel-
lular trafficking, and are used by several pathogens for infection 
(9–11). Of the 33 human Tspans, CD151, CD82, CD81, CD63, 
CD9, Tspan9, and Tspan7 have been associated with viral infec-
tions (12–16).
Structure
Structurally, Tspans consist of four transmembrane segments, a 
small extracellular domain, and a large extracellular loop (LEL). 
Intracellular domains, including the N- and C-terminal tails, are 
relatively small and contain palmitoylated cysteines. Homology is 
highly conserved between isoforms with the exception of a small 
variable domain located within the LEL (17), which may contri-
bute to differences in functionality between isoforms (18, 19).
To date, structural models are only available for CD81. The 
first model is based on the LEL crystal structure to which the 
α-helical transmembrane segments were attached in a theoretical 
conformation. The transmembrane region was predicted to form 
a four-stranded coiled-coil with two helices extending vertically 
into the bulkier LEL (20), resulting into a mushroom-shaped 
structure. The second model, derived from lipidic cubic phase 
crystallization of the entire protein, describes an arrangement 
with two major differences. First, instead of assembling into 
one bundle the transmembrane segments form two coiled-coils 
resulting in a cholesterol-binding pocket. Second, two kinks 
exist between the helical transmembrane segments and the LEL, 
causing the LEL to fold back toward the membrane (21). When 
cholesterol is released, the kinks straighten, and the LEL adopts 
an orientation similar to the proposed first model (21).
Tspan-enriched Microdomains
Tetraspanins are referred to as master organizers of the plasma 
membrane, largely due to the fact that they form functional 
units termed Tspan-enriched microdomains (TEMs or TERMs). 
Biochemical immunoprecipitation experiments employing deter-
gents of varying strengths revealed two major categories of 
Tspan interactions: (1) robust interactions between Tspans and 
non-Tspan binding partners, and (2) weak interactions between 
Tspan family members (22). Within the second category, certain 
assemblies of homo–Tspan interactions are preferred over hetero- 
dimerization/oligomerization (23), and the specificity of oligo-
merization is mediated by a small segment within the LEL 
referred to as δ-loop (24, 25). Consistent with these bioche-
mical findings, electron microscopy shows that CD63 and CD9 
form distinct clusters (26). Using a more systematic approach, 
super-resolution light microscopy confirms that single Tspan 
family members cluster within TEMs (27). Together, these data 
demonstrate that Tspan isoforms segregate into individual nano-
clusters within larger Tspan domains.
In immuno-electron microscopy, Tspan microdomains are 
highly variable in shape and size with an average surface area of 
0.2 µm2 (26). When assuming a spherical shape, this corresponds 
to a diameter of ≈500  nm. In contrast, super-resolution light 
microscopy detects spherically shaped structures with a diameter 
in the range of 100–150 nm (27, 28). These two methods result 
in surface area coverage calculations that differ by more than one 
order of magnitude. This substantial variability is likely due to the 
description of multiple nanoclusters within TEMs via electron 
microscopy, whereas super-resolution light microscopy identifies 
individual nanoclusters due to a higher epitope labeling density.
At present, the sequence of events for TEM biogenesis is 
unknown, though we can build a model on the following obser-
vations. First, different Tspans can associate with each other, but 
Tspans of one type preferentially homo-oligomerize. Second, 
Tspans form very tight complexes with non-Tspan partners such 
as integrins (29, 30) and signaling receptors (31). Finally, TEMs 
are stabilized by weak nonspecific interactions mediated by the 
aforementioned palmitate residues (32, 33) and glycolipids that 
promote Tspan assemblies (24, 34). These different interaction 
modalities likely produce small TEMs (Figure 1A). Viral surfaces 
contain abundant identical binding sites that may crosslink small 
TEMs to large Tspan trafficking platforms (Figure 1B). Evidence 
for virus-induced large Tspan assemblies has been documented by 
a number of microscopic studies discussed below.
ROLeS OF Tspans in viRUS inFeCTiOn
Tetraspanins are essential for specific steps in viral entry and 
exit (12, 13, 15). As described above, contacts between viruses 
and proteins on the cell surface can lead to large Tspan cluster 
networks or trafficking platforms (Figure  1B). Similarly, viral 
envelope proteins accumulate in TEMs during morphogenesis 
and induce large assemblies of Tspans and viral transmembrane 
proteins to facilitate efficient budding (Figure 2). These platforms 
enable the coordination of factors required for viral endocytosis, 
penetration, trafficking, and release. Here, we summarize and 
discuss the role of CD151, CD82, CD81, CD63, CD9, Tspan9, and 
Tspan7 in the life cycle of Tspan-facilitated viruses [for a detailed 
discussion on the role of Tspans in human immunodeficiency 
virus (HIV) infection see (Suarez et al.; Tspans, another piece in 
the HIV-1 replication puzzle) in this issue].
Tspan Platforms in virus endocytosis  
and Fusion
Studies investigating different viral systems show common mech-
anisms for how viruses infiltrate their target cells via Tspan 
platforms. Several microscopic studies confirm that Tspans are 
enriched at viral entry sites of human papillomaviruses (HPVs) 
(35, 36), hepatitis C virus (HCV) (37–42), coronavirus (CoV), 
influenza A virus (IAV) (43–45), and HIV (46, 47), and required 
for penetration of human cytomegalovirus (HCMV) (48) and 
alphaviruses (16, 49). These viruses use specific Tspans both as 
receptors and by compartmentalizing host entry factors.
FigURe 1 | Model of TEM building. (A) Left, random distribution of three TEM components: two tetraspanins (TspanA and TspanB) and a primary interaction partner 
of TspanA [e.g., an integrin or a growth factor receptor (GFR)]. Middle, TEM building blocks; tetraspanins (Tspans) are arranged in homomeric nanoclusters and 
integrins/GFRs form dimers. Right, building blocks are connected via strong specific interactions between TspanA and the receptor/integrin dimer and weak 
nonspecific interactions between different Tspan nanoclusters. (B) When a virus encounters the cellular membrane, virus surface molecules crosslink small TEMs to 
form larger TEMs, thereby concentrating proteins leading to the activation of intracellular signaling cascades that trigger the uptake of the Tspan trafficking platform.
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CD151 in Early Steps of HPV  
and Cytomegalovirus Entry
Host cell entry of non-enveloped DNA tumor virus HPV16 relies 
on a fine interplay between the virion and the host cell. HPV16 
binding to primary attachment sites triggers cell signaling events 
and rearrangement of the viral capsid, membrane proteins, 
and the actin cytoskeleton (15, 50–52). These processes lead to 
the formation of a virus entry complex and virus uptake via a 
CD151-dependent and clathrin-independent endocytosis path-
way (14, 15, 53). In epithelial cells, surface-bound HPV16 particles 
colocalize with locally enriched CD151 and CD63 on the plasma 
membrane during invagination and in endosomes (14, 35). 
Cellular depletion of CD151 and CD63 leads to signi ficant reduc-
tion of infections by different oncogenic HPV types, suggesting 
that these Tspans play a more general role in HPV entry (35, 36, 
54, 55). On T-cells, HPV particles are able to trigger the clustering 
of CD81 which results in the assembly of larger cluster networks 
required for particle uptake (56). Furthermore, detailed analyses 
using CD151 mutants revealed that palmitoylation, the δ-loop 
of the LEL and the C-teminus of CD151 are critical for HPV16 
endocytosis (14, 36). These findings indicate that integration of 
the virus/receptor-complex into larger TEMs and association 
with cytoplasmic factors (e.g., actin) are required for this process. 
HPV endocytosis may also involve interactions between multiple 
receptors and the viral surface, crosslinking smaller TEMs to 
larger entry platforms (Figure  1B). HPV16 receptor-complex 
components include integrins (36, 57–59), growth factor recep-
tors (GFRs) (60), the annexin A2 heterotetramer (61, 62), and 
other Tspans (35, 36, 56). CD151 directly interacts with integrins 
and GFRs (14, 22, 63, 64), and, therefore, positions these HPV 
receptors within TEMs (11, 65). Through this spatial arrangement 
of functional proteins, CD151 may control enzymatic activities 
and signaling pathways required for coordinated assembly of the 
viral entry platform and endocytosis.
Likewise, entry of the enveloped HCMV depends on CD151 
and CD151 partner proteins (e.g., integrins, GFRs) and additional 
Tspans, such as CD9 (15, 48, 66). CD151 is functionally involved 
post-binding during viral penetration (48). HCMV membrane 
FigURe 2 | Schematic model depicting the subcellular localization of tetraspanins (Tspans) during virus infection. (1) Interactions between viral particles and entry 
receptors at Tspan clusters trigger the formation of larger cluster networks. (2) Tspan assemblies promote viral internalization by endocytosis and/or fusion.  
(3) Endocytosis is followed by intracellular trafficking of virus particles in transport vesicles. During this stage, Tspans mediate and organize interactions with 
cytoplasmic trafficking molecules. (4) These steps lead to delivery of viral genomes into the cytoplasm or the nucleus and successful infection. (5) Morphogenesis  
of enveloped viruses on Tspan-enriched microdomains. (6) Integration of viral proteins into Tspan clusters induces spatial enrichment of Tspans and viral proteins.  
(7) The resulting high concentration of virus envelope components enables efficient budding and release.
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fusion occurs after clathrin-independent endocytosis in many 
cell lines (67–69). Together, these studies suggest that CD151-
mediated endocytosis might be a prerequisite for efficient HCMV 
and HPV infection. Mechanistically, virus-receptor, virus-Tspan, 
and Tspan-Tspan interactions play a vital role in organizing large 
Tspan platforms, which facilitate coordinated or simultaneous 
interactions between virus and host to induce membrane invagi-
nation by a mechanism yet to be determined [for detailed review 
see Ref. (15)].
CD81 and CD9 in HCV, Corona-,  
and Influenza-Virus Entry
Similar to HPV and HCMV, HCV entry into hepatocytes is a 
multistep process involving attachment to cell surface heparan 
sulfate proteoglycans, conformational changes, and transfer of 
viral particles to secondary receptors (38, 40, 70, 71). These secon-
dary HCV binding molecules also include integrins, the epider-
mal GFR (EGFR), the ephrin receptor A2 and Tspans as well 
as claudin-1 (CLDN1), occludin, the scavenger receptor type B 
class I (SR-BI), and the serum response factor binding protein 1 
(SRFBP1) (72–74). Tspan CD81 plays a multifunctional role in 
HCV entry. CD81 acts as a virus receptor by directly interacting 
with the HCV glycoprotein E2 (41, 42). CD81 modulates Tspan 
interactions after HCV binding (75) by triggering EGFR signal-
ing pathways, which enables Tspan/receptor complex-assembly 
(76, 77) and promotes CD81-EGFR or CD81-CLDN1 complex 
formation (74, 76). These events are prerequisite for the endo-
cytosis of CD81-HCV clusters and viral glycoprotein-dependent 
membrane fusion. Proteomic approaches confirmed complex 
formation of CLDN1, SR-BI, and SRFBP1 with CD81, and 
demonstrate the functional requirement of integrin β1 (ITGB1) 
and SRFBP1 for HCV infection and the physical interaction of 
the Tspan coreceptor-complex with the signaling molecule HRas 
(73, 77). The rat sarcoma/mitogen-activated protein kinase 
signaling pathways and EGFR or EphA2 activity trigger lateral 
diffusion of CD81 for assembly of the viral entry complex consist-
ing of CD81- CLDN1, HRas, and ITGB1 (74, 77). Because GFRs 
support the uptake of multiple viruses (78), it is probable that 
activation of their downstream signaling cascades could trigger 
Tspan receptor clustering accompanied by cytoskeletal network 
rearrangement required for the entry of other virus families.
Influenza A-viruses and CoVs are enveloped RNA viruses 
(79). Tspan microdomains, especially CD81 and CD9 enriched 
microdomains, are preferred IAV and CoV entry sites as they 
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are required for fusion of viral and host cell membranes in 
pathogenic infections by both viruses (43–45, 80, 81). IAV and 
CoV use a variety of coreceptors for this glycoprotein-catalyzed 
process (82). IAV is routed to CD81-positive endosomes and 
CD81 is functionally required for the fusion of the viral and the 
endosomal membrane (45). Here, CD81 may help organize the 
endosomal membrane and cofactors assisting influenza viral 
fusion. CoV membrane fusion is mediated by the viral spike 
glycoprotein (S) and depends on multiple events including pro-
teolytic processing and conformational change of the S protein. 
Experiments utilizing Tspan knockout cell lines and mice revealed 
that infection by the human CoV strain 229E requires the Tspan 
CD9 (43, 44). Pulldown and proximity ligation assays uncovered 
the four known CoV receptors and a fusion-activating protease 
within CD9 microdomains. These studies also demonstrated that 
even in the absence of the virus, CD9 is responsible for the local 
accumulation of the identified entry receptors. Together, this evi-
dence suggests that CoV uses pre-existing clusters of receptors, 
proteases, and Tspans for entry. Whether these viruses induce 
local accumulation of the pre-formed nanoclusters to enable 
efficient priming of the viral spike proteins during viral egress 
requires further investigation.
CD63 and Tspan9 as Regulator of virus 
Trafficking and Fusion in infections by  
Hiv, iAv, HPv, and Lujo virus (LUJv)
Tetraspanins not only organize plasma membrane molecules but 
also regulate the trafficking of cellular proteins and the transport 
of endocytosed viruses (11, 15, 83). Many viruses, including 
HIV, IAV, HPV, and LUJV, localize to CD63-positive endosomes 
during entry (35, 46, 55, 81, 84). CD63 is most abundant in late 
endosomes or multivesicular bodies (MVBs) (85) and involved 
in the membrane organization and trafficking of cellular trans-
membrane proteins that interact with viruses such as HIV-
receptor component CXCR4 (83, 86, 87). Therefore, a functional 
involvement of CD63 in viral fusion and transport is conceivable. 
Cellular depletion of CD63 or treatment of cells with CD63 
anti bodies leads to decreased infectivity of HIV-1, HCV, LUJV, 
and oncogenic HPV types presenting CD63 as a more general 
mediator of virus infection (46, 55, 84, 88–90). In contrast to the 
proviral role of CD63, it is believed that CD9 and CD81 negatively 
regulate HIV-1 entry by interfering with the formation of the 
entry receptor complex (47).
Tetraspanin CD63 forms complexes with HPV16 capsid pro-
tein L1 (55). As CD63 is involved in the transport of proteins 
to multiple subcellular locations, it is plausible that different 
adaptors are required for regulating its trafficking and sorting. 
For example, syntenin-1 modulates trafficking of CD63 by bind-
ing to its C-terminus (91). Consequently, ultrastructural analyses 
demonstrated the importance of the CD63/syntenin-1 complex 
for HPV trafficking to MVBs, a process that is required for 
capsid disassembly (55). The complexity of CD63-mediated 
viral trafficking is highlighted by the finding that components of 
the cellular endosomal sorting complex required for transport 
(ESCRT) are also integrated into the HPV transport platform 
(55, 92, 93). ESCRT proteins are able to interact with both, 
syntenin-1 and viral proteins like the HPV16 capsid protein L2 
(55, 92–97). Therefore, both viral and cytoplasmic proteins may 
be targeted to CD63 platforms in a virus-modulated endosomal 
trafficking pathway.
In addition to its role in trafficking, CD63 facilitates membrane 
fusion of enveloped viruses. For example, LUJV glycoprotein-
mediated membrane fusion is dependent on CD63 and low pH 
(84), highlighting the importance of the endo/lysosomal system 
in cell entry. Similarly, Tspan TSPAN9 promotes membrane 
penetration in early endosomes by the alphaviruses Sindbis 
virus, Semliki Forest virus, vesicular stomatitis virus, and chikun-
gunya virus (16, 49). Together, CD63 and TSPAN9 may modulate 
the endosomal compartment to be more permissive for the fusion 
of viral and cellular membranes.
Tspans in virus exit
Morphogenesis of enveloped viruses occurs on membranes of 
intracellular compartments or at the plasma membrane. Like virus 
entry, virus exit is a multi-step process driven by viral proteins. 
This process includes the targeting of viral proteins to specific 
membrane domains, local concentration of these proteins, virus 
budding, and release of virus particles. During these processes, 
Tspans are incorporated into the enveloping membrane of virions, 
such as HIV, feline immunodeficiency virus, canine distemper 
virus (CDV), HCMV, influenza, or hepatitis A virus (HAV) (98), 
implicating TEMs at the site of virus budding.
Earlier reports support this hypothesis using electron and 
fluorescence microscopy to demonstrate that the HIV core (Gag) 
and envelope (Env) proteins (26, 99–101), the HTLV-1 Gag pro-
tein (102, 103), the Marburgvirus matrix protein VP40 (104, 105), 
and influenza proteins (45) accumulate in CD9, CD63, CD81, 
and/or CD82 containing TEMs.
Studies investigating Tspan dynamics in virus budding have 
shown that the herpes simplex virus (HSV)-1 capsid protein VP26 
physically interacts with Tspan7 (earlier known as CTMP-7) 
(106), and that formation of this complex supports viral egress. 
Moreover, influenza infection induced redistribution of CD81 on 
the plasma membrane into concentrated patches of viral budding 
sites which also contain different viral proteins (45). Likewise, 
CD63 coordinates sorting of specific viral proteins into extra-
cellular vesicles, such as the major oncoprotein latent membrane 
protein 1 of the Epstein–Barr virus (107, 108). Comparable to 
influenza budding, HIV Gag insertion into the plasma mem-
brane induces recruitment of CD81 and CD9 and the coale-
scence of different membrane microdomains (100, 101, 109–111). 
Co-immunoprecipitation experiments revealed that Gag proteins 
interact, directly or indirectly, with CD81 (100). The process of 
Gag accumulation in Tspan assemblies leads to the formation 
of larger membrane domains that extend over a few hundred 
nanometers (109, 112) and contain up to 2,500 tightly packed 
Gag molecules (113). In addition, multiple studies have shown 
that modulation of Tspan expression levels and redistribution 
via anti-Tspan antibody treatment in viral or cellular membranes 
interferes with different steps of the HIV and CDV life cycle 
including virus-to-cell fusion, reverse transcription, release, and 
virus-induced cell–cell fusion (114–121). Thus, Tspans can regu-
late, for example, viral release and cell–cell fusion by controlling 
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the access of the required cellular machineries to the specific 
areas.
In addition to Tspans and viral proteins, HIV and HAV exit 
platforms accumulate cytoplasmic factors, such as components 
of the ESCRT machinery, which are required for the budding 
process (113, 122–127). This Tspan-mediated pre-assembly of 
viral and cellular proteins enables the formation of large budding 
platforms, a precondition for coordinated viral morphogenesis.
COnCLUSiOn
At present, the various interaction modalities between viral and 
cellular proteins preclude the development of a simple model for 
viral entry. Common molecular mechanisms in viral infection 
may be revealed by characterizing Tspan platforms in different 
systems, from their initial involvement at the plasma membrane 
to their roles in intracellular trafficking and viral egress (Figure 2). 
We hypothesize that active accumulation of molecules into Tspan 
platforms drives viral infection forward in a defined step-wise 
sequence.
AUTHOR COnTRiBUTiOnS
LF and TL wrote the manuscript and designed the figures.
ACKnOwLeDgMenTS
The authors are grateful to Julia R. Taylor for her critical reading 
of the manuscript.
FUnDing
The research in our laboratories is supported by grants from the 
German Research Foundation (DFG; FL 696/2-1, FL 696/3-1 | 
LA 1272/8-1).
ReFeRenCeS
1. Sowers AE, Hackenbrock CR. Rate of lateral diffusion of intramembrane 
particles: measurement by electrophoretic displacement and rerando-
mization. Proc Natl Acad Sci U S A (1981) 78(10):6246–50. doi:10.1073/
pnas.78.10.6246 
2. Takamori S, Holt M, Stenius K, Lemke EA, Grønborg M, Riedel D, et  al. 
Molecular anatomy of a trafficking organelle. Cell (2006) 127(4):831–46. 
doi:10.1016/j.cell.2006.10.030 
3. Destainville N, Schmidt TH, Lang T. Where biology meets physics – a 
converging view on membrane microdomain dynamics. Curr Top Membr  
(2016) 77:27–65. doi:10.1016/bs.ctm.2015.10.004 
4. Cossart P, Helenius A. Endocytosis of viruses and bacteria. Cold Spring 
Harb Perspect Biol (2014) 6(8):a016972. doi:10.1101/cshperspect.a016972 
5. Smith AE, Helenius A. How viruses enter animal cells. Science (2004) 304 
(5668):237–42. doi:10.1126/science.1094823 
6. Marsh M, Helenius A. Virus entry: open sesame. Cell (2006) 124(4):729–40. 
doi:10.1016/j.cell.2006.02.007 
7. White JM, Whittaker GR. Fusion of enveloped viruses in endosomes. Traffic 
(2016) 17(6):593–614. doi:10.1111/tra.12389 
8. Huang S, Yuan S, Dong M, Su J, Yu C, Shen Y, et  al. The phylogenetic 
analysis of tetraspanins projects the evolution of cell-cell interactions from 
unicellular to multicellular organisms. Genomics (2005) 86(6):674–84. 
doi:10.1016/j.ygeno.2005.08.004 
9. Charrin S, Jouannet S, Boucheix C, Rubinstein E. Tetraspanins at a glance. 
J Cell Sci (2014) 127(Pt 17):3641–8. doi:10.1242/jcs.154906 
10. Hemler ME. Tetraspanin functions and associated microdomains. Nat Rev 
Mol Cell Biol (2005) 6(10):801–11. doi:10.1038/nrm1736 
11. Berditchevski F, Rubinstein E. Tetraspanins. Dordrecht; Heidelberg; New York; 
London: Springer (2013). 1 p.
12. van Spriel AB, Figdor CG. The role of tetraspanins in the pathogenesis of 
infectious diseases. Microbes Infect (2010) 12(2):106–12. doi:10.1016/j.
micinf.2009.11.001 
13. Monk PN, Partridge LJ. Tetraspanins: gateways for infection. Infect Disord 
Drug Targets (2012) 12(1):4–17. doi:10.2174/187152612798994957 
14. Scheffer KD, Berditchevski F, Florin L. The tetraspanin CD151 in papillo-
mavirus infection. Viruses (2014) 6(2):893–908. doi:10.3390/v6020893 
15. Fast LA, Lieber D, Lang T, Florin L. Tetraspanins in infections by human 
cytomegalo- and papillomaviruses. Biochem Soc Trans (2017) 45(2):489–97. 
doi:10.1042/BST20160295 
16. Ooi YS, Stiles KM, Liu CY, Taylor GM, Kielian M. Genome-wide RNAi 
screen identifies novel host proteins required for alphavirus entry. PLoS 
Pathog (2013) 9(12):e1003835. doi:10.1371/journal.ppat.1003835 
17. Seigneuret M, Delaguillaumie A, Lagaudrière-Gesbert C, Conjeaud H. 
Structure of the tetraspanin main extracellular domain. A partially conserved 
fold with a structurally variable domain insertion. J Biol Chem (2001) 
276(43):40055–64. doi:10.1074/jbc.M105557200 
18. Stipp C, Kolesnikova T, Hemler M. Functional domains in tetraspanin proteins. 
Trends Biochem Sci (2003) 28(2):106–12. doi:10.1016/S0968-0004(02)00014-2 
19. DeSalle R, Mares R, Garcia-España A. Evolution of cysteine patterns in 
the large extracellular loop of tetraspanins from animals, fungi, plants 
and single-celled eukaryotes. Mol Phylogenet Evol (2010) 56(1):486–91. 
doi:10.1016/j.ympev.2010.02.015 
20. Seigneuret M. Complete predicted three-dimensional structure of the 
facilitator transmembrane protein and hepatitis C virus receptor CD81: 
conserved and variable structural domains in the tetraspanin superfamily. 
Biophys J (2006) 90(1):212–27. doi:10.1529/biophysj.105.069666 
21. Zimmerman B, Kelly B, McMillan BJ, Seegar TCM, Dror RO, Kruse AC, 
et  al. Crystal structure of a full-length human tetraspanin reveals a 
cholesterol-binding pocket. Cell (2016) 167(4):1041–1051.e11. doi:10.1016/j.
cell.2016.09.056 
22. Boucheix C, Rubinstein E. Tetraspanins. Cell Mol Life Sci (2001) 58(9): 
1189–205. doi:10.1007/PL00000933 
23. Kovalenko OV, Yang X, Kolesnikova TV, Hemler ME. Evidence for spe-
cific tetraspanin homodimers: inhibition of palmitoylation makes cysteine 
residues available for cross-linking. Biochem J (2004) 377(Pt 2):407–17. 
doi:10.1042/bj20031037 
24. Schmidt TH, Homsi Y, Lang T. Oligomerization of the Tetraspanin CD81 via 
the Flexibility of Its δ-Loop. Biophys J (2016) 110(11):2463–74. doi:10.1016/ 
j.bpj.2016.05.003 
25. Homsi Y, Lang T. The specificity of homomeric clustering of CD81 is mediated 
by its δ-loop. FEBS Open Bio (2017) 7(2):274–83. doi:10.1002/2211-5463.12187 
26. Nydegger S, Khurana S, Krementsov D, Foti M, Thali M. Mapping of 
tetraspanin-enriched microdomains that can function as gateways for 
HIV-1. J Cell Biol (2006) 173(5):795. doi:10.1083/jcb.200508165 
27. Zuidscherwoude M, Göttfert F, Dunlock VME, Figdor CG, van den Bogaart G, 
van Spriel AB. The tetraspanin web revisited by super-resolution microscopy. 
Sci Rep (2015) 5:12201. doi:10.1038/srep12201 
28. Termini CM, Cotter ML, Marjon KD, Buranda T, Lidke KA, Gillette JM. 
The membrane scaffold CD82 regulates cell adhesion by altering α4 inte-
grin stability and molecular density. Mol Biol Cell (2014) 25(10):1560–73. 
doi:10.1091/mbc.E13-11-0660 
29. Berditchevski F. Complexes of tetraspanins with integrins: more than meets 
the eye. J Cell Sci (2001) 114(23):4143–51. 
30. Bassani S, Cingolani LA. Tetraspanins: interactions and interplay with integrins. 
Int J Biochem Cell Biol (2012) 44(5):703–8. doi:10.1016/j.biocel.2012.01.020 
31. Termini CM, Gillette JM. Tetraspanins function as regulators of cellular 
signaling. Front Cell Dev Biol (2017) 5:34. doi:10.3389/fcell.2017.00034 
32. Yang X, Claas C, Kraeft S-K, Chen LB, Wang Z, Kreidberg JA, et al. Palmitoy-
lation of tetraspanin proteins: modulation of CD151 lateral interactions, 
7Florin and Lang Tspan Assemblies in Virus Infection
Frontiers in Immunology | www.frontiersin.org May 2018 | Volume 9 | Article 1140
subcellular distribution, and integrin-dependent cell morphology. Mol Biol 
Cell (2002) 13(3):767–81. doi:10.1091/mbc.01-05-0275 
33. Charrin S, Manié S, Oualid M, Billard M, Boucheix C, Rubinstein E. 
Differential stability of tetraspanin/tetraspanin interactions: role of palmi-
toylation. FEBS Lett (2002) 516(1–3):139–44. doi:10.1016/S0014-5793(02) 
02522-X 
34. Kawakami Y, Kawakami K, Steelant WFA, Ono M, Baek RC, Handa K, et al. 
Tetraspanin CD9 is a “proteolipid,” and its interaction with alpha 3 integrin 
in microdomain is promoted by GM3 ganglioside, leading to inhibition of 
laminin-5-dependent cell motility. J Biol Chem (2002) 277(37):34349–58. 
doi:10.1074/jbc.M200771200 
35. Spoden G, Freitag K, Husmann M, Boller K, Sapp M, Lambert C, et  al. 
Clathrin- and caveolin-independent entry of human papillomavirus type 
16 – involvement of tetraspanin-enriched microdomains (TEMs). PLoS One 
(2008) 3(10):e3313. doi:10.1371/journal.pone.0003313 
36. Scheffer KD, Gawlitza A, Spoden GA, Zhang XA, Lambert C, Berditchevski F, 
et  al. Tetraspanin CD151 Mediates Papillomavirus Type 16 Endocytosis. 
J Virol (2013) 87(6):3435–46. doi:10.1128/JVI.02906-12
37. Bartosch B, Vitelli A, Granier C, Goujon C, Dubuisson J, Pascale S, et  al. 
Cell entry of hepatitis C virus requires a set of co-receptors that include 
the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem  
(2003) 278(43):41624–30. doi:10.1074/jbc.M305289200 
38. Farquhar MJ, Harris HJ, McKeating JA. Hepatitis C virus entry and the 
tetraspanin CD81. Biochem Soc Trans (2011) 39(2):532–6. doi:10.1042/
BST0390532 
39. Zhu Y-Z, Luo Y, Cao M-M, Liu Y, Liu X-Q, Wang W, et  al. Significance 
of palmitoylation of CD81 on its association with tetraspanin-enriched 
microdomains and mediating hepatitis C virus cell entry. Virology (2012) 
429(2):112–23. doi:10.1016/j.virol.2012.03.002 
40. Fénéant L, Levy S, Cocquerel L. CD81 and hepatitis C virus (HCV) infec-
tion. Viruses (2014) 6(2):535–72. doi:10.3390/v6020535 
41. Grigorov B, Reungoat E, Gentil Dit Maurin A, Varbanov M, Blaising J, 
Michelet M, et  al. Hepatitis C virus infection propagates through interac-
tions between Syndecan-1 and CD81 and impacts the hepatocyte glycocalyx. 
Cell Microbiol (2017) 19(5):e12711. doi:10.1111/cmi.12711
42. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, et  al.  
Binding of hepatitis C virus to CD81. Science (1998) 282(5390):938–41. 
doi:10.1126/science.282.5390.938 
43. Earnest JT, Hantak MP, Park J-E, Gallagher T. Coronavirus and influenza 
virus proteolytic priming takes place in tetraspanin-enriched membrane 
microdomains. J Virol (2015) 89(11):6093–104. doi:10.1128/JVI.00543-15 
44. Earnest JT, Hantak MP, Li K, McCray PB, Perlman S, Gallagher T. 
The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding 
host cell receptors and proteases. PLoS Pathog (2017) 13(7):e1006546. 
doi:10.1371/journal.ppat.1006546 
45. He J, Sun E, Bujny MV, Kim D, Davidson MW, Zhuang X. Dual function 
of CD81 in influenza virus uncoating and budding. PLoS Pathog (2013) 
9(10):e1003701. doi:10.1371/journal.ppat.1003701 
46. Fu E, Pan L, Xie Y, Mu D, Liu W, Jin F, et al. Tetraspanin CD63 is a regulator 
of HIV-1 replication. Int J Clin Exp Pathol (2015) 8(2):1184–98. 
47. Gordón-Alonso M, Yañez-Mó M, Barreiro O, Alvarez S, Muñoz- 
Fernández MA, Valenzuela-Fernández A, et al. Tetraspanins CD9 and CD81 
modulate HIV-1-induced membrane fusion. J Immunol (2006) 177(8): 
5129–37. doi:10.4049/jimmunol.177.8.5129 
48. Hochdorfer D, Florin L, Sinzger C, Lieber D. Tetraspanin CD151 pro-
motes initial events in human cytomegalovirus infection. J Virol (2016) 
90(14):6430–42. doi:10.1128/JVI.00145-16 
49. Stiles KM, Kielian M. Role of TSPAN9 in alphavirus entry and early endo-
somes. J Virol (2016) 90(9):4289–97. doi:10.1128/JVI.00018-16 
50. Raff AB, Woodham AW, Raff LM, Skeate JG, Yan L, Da Silva DM, et  al.  
The evolving field of human papillomavirus receptor research: a review of 
binding and entry. J Virol (2013) 87(11):6062–72. doi:10.1128/JVI.00330-13
51. Day PM, Schelhaas M. Concepts of papillomavirus entry into host cells. 
Curr Opin Virol (2014) 4:24–31. doi:10.1016/j.coviro.2013.11.002 
52. Florin L, Sapp M, Spoden GA. Host-cell factors involved in papilloma-
virus entry. Med Microbiol Immunol (2012) 201(4):437–48. doi:10.1007/
s00430-012-0270-1 
53. Bienkowska-Haba M, Sapp M. The Cytoskeleton in Papillomavirus Infec-
tion. Viruses (2011) 3(3):260–71. doi:10.3390/v3030260 
54. Spoden G, Kühling L, Cordes N, Frenzel B, Sapp M, Boller K, et al. Human 
papillomavirus types 16, 18, and 31 share similar endocytic requirements 
for entry. J Virol (2013) 87(13):7765–73. doi:10.1128/JVI.00370-13 
55. Gräßel L, Fast LA, Scheffer KD, Boukhallouk F, Spoden GA, Tenzer S, 
et al. The CD63-Syntenin-1 complex controls post-endocytic trafficking of 
oncogenic human papillomaviruses. Sci Rep (2016) 6:32337. doi:10.1038/
srep32337 
56. Homsi Y, Schloetel J-G, Scheffer KD, Schmidt TH, Destainville N, Florin L, 
et  al. The extracellular δ-domain is essential for the formation of CD81 
tetraspanin webs. Biophys J (2014) 107(1):100–13. doi:10.1016/j.bpj.2014. 
05.028 
57. Evander M, Frazer IH, Payne E, Qi YM, Hengst K, McMillan NA. Identifi-
cation of the alpha6 integrin as a candidate receptor for papillomaviruses. 
J Virol (1997) 71(3):2449–56. 
58. McMillan N, Payne E, Frazer I, Evander M. Expression of the [alpha] 6 
integrin confers papillomavirus binding upon receptor-negative B-cells. 
Virology (1999) 261(2):271–9. doi:10.1006/viro.1999.9825 
59. Yoon C, Kim K, Park S, Cheong S. [alpha] 6 Integrin is the main receptor of 
human papillomavirus type 16 VLP. Biochem Biophys Res Commun (2001) 
283(3):668–73. doi:10.1006/bbrc.2001.4838 
60. Surviladze Z, Dziduszko A, Ozbun MA. Essential roles for soluble virion- 
associated heparan sulfonated proteoglycans and growth factors in human 
papillomavirus infections. PLoS Pathog (2012) 8(2):e1002519. doi:10.1371/
journal.ppat.1002519 
61. Woodham AW, Da Silva DM, Skeate JG, Raff AB, Ambroso MR, Brand HE, 
et  al. The S100A10 subunit of the annexin A2 heterotetramer facilitates 
L2-mediated human papillomavirus infection. PLoS One (2012) 7(8):e43519. 
doi:10.1371/journal.pone.0043519 
62. Dziduszko A, Ozbun MA. Annexin A2 and S100A10 regulate human 
papillomavirus type 16 entry and intracellular trafficking in human kerati-
nocytes. J Virol (2013) 87(13):7502–15. doi:10.1128/JVI.00519-13
63. Bailey RL, Herbert JM, Khan K, Heath VL, Bicknell R, Tomlinson MG. 
The emerging role of tetraspanin microdomains on endothelial cells. Bio­
chem Soc Trans (2011) 39(6):1667–73. doi:10.1042/BST20110745 
64. Levy S, Shoham T. Protein-protein interactions in the tetraspanin web. 
Physiology (Bethesda) (2005) 20(4):218–24. doi:10.1152/physiol.00015.2005
65. Hemler ME. Specific tetraspanin functions. J Cell Biol (2001) 155(7):1103–7. 
doi:10.1083/jcb.200108061 
66. Kabanova A, Marcandalli J, Zhou T, Bianchi S, Baxa U, Tsybovsky Y, 
et  al. Platelet-derived growth factor-α receptor is the cellular receptor for 
human cytomegalovirus gHgLgO trimer. Nat Microbiol (2016) 1(8):16082. 
doi:10.1038/nmicrobiol.2016.82 
67. Hetzenecker S, Helenius A, Krzyzaniak MA. HCMV induces macropino-
cytosis for host cell entry in fibroblasts. Traffic (2016) 17(4):351–68. 
doi:10.1111/tra.12355 
68. Haspot F, Lavault A, Sinzger C, Sampaio KL, Stierhof Y-D, Pilet P, et al. Human 
cytomegalovirus entry into dendritic cells occurs via a macropinocytosis- 
like pathway in a pH-independent and cholesterol-dependent manner. 
PLoS One (2012) 7(4):e34795. doi:10.1371/journal.pone.0034795 
69. Li Q, Fischer E, Cohen JI. Cell surface THY-1 contributes to human 
cytomegalovirus entry via a macropinocytosis-like process. J Virol (2016) 
90(21):9766–81. doi:10.1128/JVI.01092-16
70. Bonander N, Jamshad M, Hu K, Farquhar MJ, Stamataki Z, Balfe P, et  al. 
Structural characterization of CD81-Claudin-1 hepatitis C virus receptor 
complexes. Biochem Soc Trans (2011) 39(2):537–40. doi:10.1042/BST0390537 
71. Zona L, Tawar RG, Zeisel MB, Xiao F, Schuster C, Lupberger J, et al. CD81-
receptor associations – impact for hepatitis C virus entry and antiviral 
therapies. Viruses (2014) 6(2):875–92. doi:10.3390/v6020875 
72. Schäfer G, Blumenthal MJ, Katz AA. Interaction of human tumor viruses 
with host cell surface receptors and cell entry. Viruses (2015) 7(5):2592–617. 
doi:10.3390/v7052592 
73. Gerold G, Meissner F, Bruening J, Welsch K, Perin PM, Baumert TF, et al. 
Quantitative proteomics identifies serum response factor binding protein 1 
as a host factor for hepatitis C virus entry. Cell Rep (2015) 12(5):864–78. 
doi:10.1016/j.celrep.2015.06.063 
74. Lupberger J, Zeisel MB, Xiao F, Thumann C, Fofana I, Zona L, et  al.  
EGFR and EphA2 are host factors for hepatitis C virus entry and possible 
targets for antiviral therapy. Nat Med (2011) 17(5):589–95. doi:10.1038/
nm.2341 
8Florin and Lang Tspan Assemblies in Virus Infection
Frontiers in Immunology | www.frontiersin.org May 2018 | Volume 9 | Article 1140
75. Harris HJ, Farquhar MJ, Mee CJ, Davis C, Reynolds GM, Jennings A, et al. 
CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry. 
J Virol (2008) 82(10):5007–20. doi:10.1128/JVI.02286-07
76. Diao J, Pantua H, Ngu H, Komuves L, Diehl L, Schaefer G, et al. Hepatitis 
C virus induces epidermal growth factor receptor activation via CD81 
binding for viral internalization and entry. J Virol (2012) 86(20):10935–49. 
doi:10.1128/JVI.00750-12
77. Zona L, Lupberger J, Sidahmed-Adrar N, Thumann C, Harris HJ, Barnes A, 
et al. HRas signal transduction promotes hepatitis C virus cell entry by trig-
gering assembly of the host tetraspanin receptor complex. Cell Host Microbe 
(2013) 13(3):302–13. doi:10.1016/j.chom.2013.02.006 
78. Zheng K, Kitazato K, Wang Y. Viruses exploit the function of epidermal 
growth factor receptor. Rev Med Virol (2014) 24(4):274–86. doi:10.1002/
rmv.1796 
79. Perlman S, Netland J. Coronaviruses post-SARS: update on replication 
and pathogenesis. Nat Rev Microbiol (2009) 7(6):439–50. doi:10.1038/
nrmicro2147 
80. König R, Stertz S, Zhou Y, Inoue A, Hoffmann H-H, Bhattacharyya S, et al. 
Human host factors required for influenza virus replication. Nature (2010) 
463(7282):813–7. doi:10.1038/nature08699 
81. Karlas A, Machuy N, Shin Y, Pleissner K-P, Artarini A, Heuer D, et  al.  
Genome-wide RNAi screen identifies human host factors crucial for influenza 
virus replication. Nature (2010) 463(7282):818–22. doi:10.1038/nature08760 
82. Li F. Receptor recognition mechanisms of coronaviruses: a decade of struc-
tural studies. J Virol (2015) 89(4):1954–64. doi:10.1128/JVI.02615-14 
83. Berditchevski F, Odintsova E. Tetraspanins as regulators of protein traffick-
ing. Traffic (2007) 8(2):89–96. doi:10.1111/j.1600-0854.2006.00515.x 
84. Raaben M, Jae LT, Herbert AS, Kuehne AI, Stubbs SH, Chou Y-Y, et  al.  
NRP2 and CD63 are host factors for lujo virus cell entry. Cell Host Microbe 
(2017) 22(5):688–96.e5. doi:10.1016/j.chom.2017.10.002 
85. Pols MS, Klumperman J. Trafficking and function of the tetraspanin CD63. 
Exp Cell Res (2009) 315(9):1584–92. doi:10.1016/j.yexcr.2008.09.020 
86. Schulze U, Brast S, Grabner A, Albiker C, Snieder B, Holle S, et al. Tetra spanin 
CD63 controls basolateral sorting of organic cation transporter 2 in renal 
proximal tubules. FASEB J (2016) 31(4):1421–33. doi:10.1096/fj.201600901R 
87. Yoshida T, Kawano Y, Sato K, Ando Y, Aoki J, Miura Y, et al. A CD63 mutant 
inhibits T-cell tropic human immunodeficiency virus type 1 entry by disrupt-
ing CXCR4 trafficking to the plasma membrane. Traffic (2008) 9(4):540–58. 
doi:10.1111/j.1600-0854.2008.00700.x 
88. Park JH, Park S, Yang J-S, Kwon OS, Kim S, Jang SK. Discovery of cellular 
proteins required for the early steps of HCV infection using integrative 
genomics. PLoS One (2013) 8(4):e60333. doi:10.1371/journal.pone.0060333
89. Li G, Endsley MA, Somasunderam A, Gbota SL, Mbaka MI, Murray JL, 
et al. The dual role of tetraspanin CD63 in HIV-1 replication. Virol J (2014) 
11(1):23. doi:10.1186/1743-422X-11-23 
90. Lindern von J, Rojo D, Grovit-Ferbas K, Yeramian C, Deng C, Herbein G, et al. 
Potential role for CD63 in CCR5-mediated human immunodeficiency virus 
type 1 infection of macrophages. J Virol (2003) 77(6):3624–33. doi:10.1128/
JVI.77.6.3624-3633.2003
91. Latysheva N, Muratov G, Rajesh S, Padgett M, Hotchin NA, Overduin M, 
et  al. Syntenin-1 is a new component of tetraspanin-enriched micro-
domains: mechanisms and consequences of the interaction of syntenin-1 
with CD63. Mol Cell Biol (2006) 26(20):7707–18. doi:10.1128/MCB.00849-06 
92. Broniarczyk J, Bergant M, Goździcka-Józefiak A, Banks L. Human papillo-
mavirus infection requires the TSG101 component of the ESCRT machinery. 
Virology (2014) 460-461:83–90. doi:10.1016/j.virol.2014.05.005 
93. Broniarczyk J, Pim D, Massimi P, Bergant M, Goździcka-Józefiak A, 
Crump C, et  al. The VPS4 component of the ESCRT machinery plays an 
essential role in HPV infectious entry and capsid disassembly. Sci Rep (2017) 
28(7):45159. doi:10.1038/srep45159 
94. Hurley JH, Boura E, Carlson L-A, Różycki B. Membrane budding. Cell (2010) 
143(6):875–87. doi:10.1016/j.cell.2010.11.030 
95. Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, et al. 
Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nature 
(2012) 14(7):677–85. doi:10.1038/ncb2502 
96. Ghossoub R, Lembo F, Rubio A, Gaillard CB, Bouchet J, Vitale N, et  al. 
Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies 
are controlled by ARF6 and PLD2. Nat Commun (2014) 18:5. doi:10.1038/
ncomms4477 
97. Bissig C, Gruenberg J. ALIX and the multivesicular endosome: ALIX in 
Wonderland. Trends Cell Biol (2014) 24(1):19–25. doi:10.1016/j.tcb.2013. 
10.009 
98. Pelchen-Matthews A, Kramer B, Marsh M. Infectious HIV-1 assembles in 
late endosomes in primary macrophages. J Cell Biol (2003) 162(3):443–55. 
doi:10.1083/jcb.200304008
99. Jolly C, Sattentau QJ. Human immunodeficiency virus type 1 assembly, 
budding, and cell-cell spread in T cells take place in tetraspanin-enriched 
plasma membrane domains. J Virol (2007) 81(15):7873–84. doi:10.1128/
JVI.01845-06
100. Grigorov B, Attuil-Audenis V, Perugi F, Nedelec M, Watson S, Pique C, 
et al. A role for CD81 on the late steps of HIV-1 replication in a chronically 
infected T cell line. Retrovirology (2009) 6(1):28. doi:10.1186/1742-4690-6-28 
101. Ono A. Relationships between plasma membrane microdomains and 
HIV-1 assembly. Biol Cell (2010) 102(6):335–50. doi:10.1042/BC20090165 
102. Mazurov D, Heidecker G, Derse D. HTLV-1 Gag protein associates with 
CD82 tetraspanin microdomains at the plasma membrane. Virology (2006) 
346(1):194–204. doi:10.1016/j.virol.2005.10.033 
103. Mazurov D, Heidecker G, Derse D. The inner loop of tetraspanins CD82 
and CD81 mediates interactions with human T  cell lymphotrophic virus 
type 1 Gag protein. J Biol Chem (2007) 282(6):3896–903. doi:10.1074/jbc.
M607322200 
104. Kolesnikova L, Bohil AB, Cheney RE, Becker S. Budding of Marburgvirus 
is associated with filopodia. Cell Microbiol (2007) 9(4):939–51. doi:10.1111/ 
j.1462-5822.2006.00842.x 
105. Makino A, Yamayoshi S, Shinya K, Noda T, Kawaoka Y. Identification of 
amino acids in Marburg virus VP40 that are important for virus-like particle 
budding. J Infect Dis (2011) 204(Suppl 3):S871–7. doi:10.1093/infdis/jir309 
106. Wang L, Liu L, Che Y, Wang L, Jiang L, Dong C, et  al. Egress of HSV-1 
capsid requires the interaction of VP26 and a cellular tetraspanin membrane 
protein. Virol J (2010) 7(1):156. doi:10.1186/1743-422X-7-156 
107. Hurwitz SN, Nkosi D, Conlon MM, York SB, Liu X, Tremblay DC, et  al.  
CD63 regulates Epstein-Barr virus LMP1 exosomal packaging, enhan cement 
of vesicle production, and noncanonical NF-κB signaling. J Virol (2017) 
91(5):e02251-16. doi:10.1128/JVI.02251-16
108. Hurwitz SN, Cheerathodi MR, Nkosi D, York SB, Meckes DG. Tetraspanin 
CD63 bridges autophagic and endosomal processes to regulate exosomal 
secretion and intracellular signaling of Epstein-Barr virus LMP1. J Virol 
(2018) 92(5):e01969-17. doi:10.1128/JVI.01969-17 
109. Krementsov DN, Rassam P, Margeat E, Roy NH, Schneider-Schaulies J, 
Milhiet P-E, et al. HIV-1 assembly differentially alters dynamics and parti-
tioning of tetraspanins and raft components. Traffic (2010) 11(11):1401–14. 
doi:10.1111/j.1600-0854.2010.01111.x 
110. Hogue IB, Grover JR, Soheilian F, Nagashima K, Ono A. Gag induces 
the coalescence of clustered lipid rafts and tetraspanin-enriched micro-
domains at HIV-1 assembly sites on the plasma membrane. J Virol (2011) 
85(19):9749–66. doi:10.1128/JVI.00743-11 
111. Mariani C, Desdouits M, Favard C, Benaroch P, Muriaux DM. Role of 
Gag and lipids during HIV-1 assembly in CD4(+) T cells and macrophages. 
Front Microbiol (2014) 5:312. doi:10.3389/fmicb.2014.00312 
112. Nydegger S, Foti M, Derdowski A, Spearman P, Thali M. HIV-1 egress is 
gated through late endosomal membranes. Traffic (2003) 4(12):902–10. 
doi:10.1046/j.1600-0854.2003.00145.x 
113. Mücksch F, Laketa V, Müller B, Schultz C, Kräusslich H-G. Synchronized 
HIV assembly by tunable PIP2 changes reveals PIP2 requirement for stable 
Gag anchoring. Elife (2017) 6:e25287. doi:10.7554/eLife.25287 
114. Krementsov DN, Weng J, Lambelé M, Roy NH, Thali M. Tetraspanins regulate 
cell-to-cell transmission of HIV-1. Retrovirology (2009) 6:64. doi:10.1186/ 
1742-4690-6-64 
115. Sato K, Aoki J, Misawa N, Daikoku E, Sano K, Tanaka Y, et al. Modulation of 
human immunodeficiency virus type 1 infectivity through incorporation of 
tetraspanin proteins. J Virol (2008) 82(2):1021–33. doi:10.1128/JVI.01044-07
116. Weng J, Krementsov DN, Khurana S, Roy NH, Thali M. Formation of syn-
cytia is repressed by tetraspanins in human immunodeficiency virus type 
1-producing cells. J Virol (2009) 83(15):7467–74. doi:10.1128/JVI.00163-09 
117. Schmid E, Zurbriggen A, Gassen U, Rima B, Meulen ter V, Schneider-
Schaulies J. Antibodies to CD9, a tetraspan transmembrane protein, inhibit 
canine distemper virus-induced cell-cell fusion but not virus-cell fusion. 
J Virol (2000) 74(16):7554–61. doi:10.1128/JVI.74.16.7554-7561.2000
9Florin and Lang Tspan Assemblies in Virus Infection
Frontiers in Immunology | www.frontiersin.org May 2018 | Volume 9 | Article 1140
118. Singethan K, Topfstedt E, Schubert S, Duprex WP, Rima BK, Schneider-
Schaulies J. CD9-dependent regulation of Canine distemper virus-in-
duced cell-cell fusion segregates with the extracellular domain of the 
haemagglu tinin. J Gen Virol (2006) 87(Pt 6):1635–42. doi:10.1099/vir.0. 
81629-0 
119. Singethan K, Müller N, Schubert S, Lüttge D, Krementsov DN, Khurana SR, 
et  al. CD9 clustering and formation of microvilli zippers between contac-
ting cells regulates virus-induced cell fusion. Traffic (2008) 9(6):924–35. 
doi:10.1111/j.1600-0854.2008.00737.x 
120. Rocha-Perugini V, Suárez H, Alvarez S, López-Martín S, Lenzi GM, 
Vences-Catalán F, et al. CD81 association with SAMHD1 enhances HIV-1 
reverse transcription by increasing dNTP levels. Nat Microbiol (2017) 2(11): 
1513–22. doi:10.1038/s41564-017-0019-0 
121. Ménager MM, Littman DR. Actin dynamics regulates dendritic cell-mediated 
transfer of HIV-1 to T cells. Cell (2016) 164(4):695–709. doi:10.1016/j.cell. 
2015.12.036 
122. Ono A, Freed E. Cell-type-dependent targeting of human immuno deficiency 
virus type 1 assembly to the plasma membrane and the multivesi cular body. 
J Virol (2004) 78(3):1552–63. doi:10.1128/JVI.78.3.1552-1563.2004
123. Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, Bess JW, et  al. 
Proteomic and biochemical analysis of purified human immunodeficiency 
virus type 1 produced from infected monocyte-derived macrophages. J Virol 
(2006) 80(18):9039–52. doi:10.1128/JVI.01013-06
124. Fujii K, Hurley JH, Freed EO. Beyond Tsg101: the role of Alix in “ESCRTing” 
HIV-1. Nat Rev Microbiol (2007) 5(12):912–6. doi:10.1038/nrmicro1790 
125. Sundquist WI, Kräusslich H-G. HIV-1 assembly, budding, and maturation. 
Cold Spring Harb Perspect Med (2012) 2(7):a006924. doi:10.1101/cshper-
spect.a006924 
126. McKnight KL, Xie L, González-López O, Rivera-Serrano EE, Chen X, 
Lemon SM. Protein composition of the hepatitis A virus quasi-envelope. 
Proc Natl Acad Sci U S A (2017) 114(25):6587–92. doi:10.1073/pnas.1 
619519114 
127. Scourfield EJ, Martin-Serrano J. Growing functions of the ESCRT machinery 
in cell biology and viral replication. Biochem Soc Trans (2017) 45(3):613–34. 
doi:10.1042/BST20160479 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2018 Florin and Lang. This is an open­access article distributed under the 
terms of the Creative Commons Attribution License (CC BY). The use, distribution 
or reproduction in other forums is permitted, provided the original author(s) and the 
copyright owner are credited and that the original publication in this journal is cited, 
in accordance with accepted academic practice. No use, distribution or reproduction 
is permitted which does not comply with these terms.
